Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Detection of depressant components of drug activity.

REINHARD JF, SCUDI JV.

Proc Soc Exp Biol Med. 1959 Feb;100(2):381-3. No abstract available.

PMID:
13634146
2.

Chemotherapeutic activity of some sulfapyridine-1-oxides.

SCUDI JV, PLEKSS OJ.

Proc Soc Exp Biol Med. 1958 Mar;97(3):639-41. No abstract available.

PMID:
13518359
3.

Constitution of the hydroxysulfapyridine isolated from dog urine.

SCUDI JV, CHILDRESS SJ.

J Biol Chem. 1956 Feb;218(2):587-93. No abstract available.

4.

Chemotherapeutic activity of some hydroxysulfapyridines.

SCUDI JV, CHILDRESS SJ, PLEKSS OJ.

Proc Soc Exp Biol Med. 1955 Aug;89(4):571-3. No abstract available.

PMID:
13254828
5.

Pharmacologic characteristics of 1-(ortho-toluoxy)2, 3-bis-(2, 2, 2-trichloro-1-hydroxyethoxy)-propane.

REINHARD JF, KIMURA ET, SCUDI JV.

J Pharmacol Exp Ther. 1952 Dec;106(4):444-52. No abstract available.

PMID:
13023555
6.

Studies in experimental tuberculosis; in vitro and in vivo activities of thiosemicarbazones.

DUCA CJ, ROTHLAUF MV, SCUDI JV.

Antibiot Chemother (Northfield). 1952 Jan;2(1):16-20. No abstract available.

PMID:
24541731
7.

Antispasmodic and local anesthetic activity of dimethylaminoethyl substituted compounds.

REINHARD JF, KIMURA ET, SCUDI JV.

J Pharmacol Exp Ther. 1951 Nov;103(3):288-92. No abstract available.

PMID:
14898444
8.

In vitro antibacterial activity of dimethylaminoethyl substituted compounds.

DUCA CJ, ROTHLAUF MV, SCUDI JV.

Proc Soc Exp Biol Med. 1951 Oct;78(1):99-100. No abstract available.

PMID:
14891933
9.

Further studies on thonzylamine in treatment of experimental tuberculosis.

DUCA CJ, ROTHLAUF MV, SCUDI JV.

Proc Soc Exp Biol Med. 1951 Aug;77(4):641-3. No abstract available.

PMID:
14891823
10.

Study of drug action on mammalian ciliated epithelium.

SCUDI JV, KIMURA ET, REINHARD JF.

J Pharmacol Exp Ther. 1951 Jun;102(2):132-7. No abstract available.

PMID:
14841597
11.

Daily administration of massive oral doses of thonzylamine hydro-chloride.

REINHARD JF, SCUDI JV.

Proc Soc Exp Biol Med. 1950 May;74(1):190-1. No abstract available.

PMID:
15430430
12.

Neohetramine in the treatment of experimental tuberculosis.

DUCA CJ, SCUDI JV.

Ann Allergy. 1949 May-Jun;7(3):318. No abstract available.

PMID:
18131363
13.

Some antibacterial properties of mandelamine.

SCUDI JV, DUCA CJ.

J Urol. 1949 Feb;61(2):459-67. No abstract available.

PMID:
18111866
14.

Absorption, distribution, and renal excretion of mandelamine.

SCUDI JV, REINHARD JF.

J Lab Clin Med. 1948 Oct;33(10):1304-10. No abstract available.

PMID:
18886329
15.

Pharmacologic characteristics of neohetramine, a new antihistaminic drug.

SCUDI JV, REINHARD JF, DREYER NB.

J Allergy. 1948 May;19(3):184-99. No abstract available.

PMID:
18858080
16.

Pharmacological characteristics of neochetramine, a new antihistaminic drug.

SCUDI JV, REINHARD JF, DREYER NB.

Fed Proc. 1948 Mar;7(1 Pt 1):186. No abstract available.

PMID:
18938804
17.

Bacteriological characteristics of mandelamine.

SCUDI JV, DUCA CJ.

Fed Proc. 1948 Mar;7(1 Pt 1):186. No abstract available.

PMID:
18938803
18.

Chemotherapy of tuberculosis; in vitro and in vivo activities of various compounds.

DUCA CJ, WILLIAMS RD, SCUDI JV.

Proc Soc Exp Biol Med. 1948 Feb;67(2):159-62. No abstract available.

PMID:
18907614
19.

Some pharmacological characteristics of bacitracin; chronic toxicity studies of commercial bacitracin in the dog and monkey.

SCUDI JV, CORET IA, ANTOPOL W.

Proc Soc Exp Biol Med. 1947 Dec;66(3):558-61. No abstract available.

PMID:
18900024
20.

Pharmacological characteristics of neohetramine, a new antihistaminic drug.

REINHARD JF, SCUDI JV, et al.

Proc Soc Exp Biol Med. 1947 Dec;66(3):512-6. No abstract available.

PMID:
18900008
21.

Some antibacterial properties of mandelamine (methenamine mandelate).

DUCA CJ, SCUDI JV.

Proc Soc Exp Biol Med. 1947 Oct;66(1):123-6. No abstract available.

PMID:
20270696
22.

The excretion of N15 in the urine of dogs after the administration of labeled pentobarbital.

VAN DYKE HB, SCUDI JV, TABERN DL.

J Pharmacol Exp Ther. 1947 Aug;90(4):364-6. No abstract available.

PMID:
20265814
23.

Some pharmacological characteristics of bacitracin; absorption and excretion of bacitracin in the dog.

SCUDI JV, CLIFT ME, KRUEGER RA.

Proc Soc Exp Biol Med. 1947 May;65(1):9-13. No abstract available.

PMID:
20243102
24.

Some pharmacological characteristics of bacitracin.

SCUDI JV, ANTOPOL W.

Proc Soc Exp Biol Med. 1947 Apr;64(4):503-6. No abstract available.

PMID:
20239470
25.

A color reaction given by streptomycin.

SCUDI JV, BOXER GE, JELINEK VC.

Science. 1946 Nov 22;104(2708):486. No abstract available.

PMID:
21002764
26.

A Color Reaction Given by Streptomycin.

Scudi JV, Boxer GE, Jelinek VC.

Science. 1946 Nov 22;104(2708):486-7. No abstract available.

PMID:
17734650
27.

A rapid micromethod for the fluorometric determination of penicillin.

SCUDI JV, JELINEK VC.

J Biol Chem. 1946 Jul;164:195-201. No abstract available.

PMID:
20989480
28.

A colorimetric method for the determination of penicillin.

SCUDI JV.

J Biol Chem. 1946 Jul;164:183-94. No abstract available.

PMID:
20989479
29.

On the fluorometric determination of nicotinamide.

SCUDI JV.

Science. 1946 May 3;103(2679):567. No abstract available.

PMID:
21026822
30.

On the Fluorometric Determination of Nicotinamide.

Scudi JV.

Science. 1946 May 3;103(2679):567-8. No abstract available.

PMID:
17800118
31.

Sulfonamide urolithiasis.

SCUDI JV.

Am J Med Sci. 1946 May;211:615-28. No abstract available.

PMID:
21026502
32.

ON THE INHIBITION OF UREASE BY PENICILLIN.

Scudi JV, Jelinek VC.

Science. 1944 Oct 6;100(2597):312-3. No abstract available.

PMID:
17745810
33.

ON THE URINARY EXCRETION OF "FREE" SULFAPYRIDINE.

Scudi JV.

Science. 1940 May 17;91(2368):486. No abstract available.

PMID:
17810649
34.

INCREASED GLYCURONATE EXCRETION FOLLOWING ADMINISTRATION OF SULFAPYRIDINE.

Scudi JV, Ratish HD, Bullowa JG.

Science. 1939 Jun 2;89(2318):516. No abstract available.

PMID:
17776590

Supplemental Content

Loading ...
Support Center